Morning Watch List : Bristol-Myers Squibb (NYSE:BMY), The Procter & Gamble (NYSE:PG), Nordic American Offshore (NYSE:NAO), Infinera (NASDAQ:INFN), Dr. Reddy’s Laboratories (NYSE:RDY),

Bristol-Myers Squibb Company (NYSE:BMY) announced Tuesday its plans to build a 650,000-square-foot office building in the township at the intersection of Princeton Pike and Interstate 95. Bristol-Myers Squibb Company (NYSE:BMY) belongs to Healthcare sector. Its net profit margin is 16.60% and weekly performance is 0.98%. On last trading day company shares ended up $51.62. Bristol-Myers Squibb Company (NYSE:BMY) distance from 50-day simple moving average (SMA50) is 2.92%.

The Procter & Gamble Company (NYSE:PG) is reportedly the focus of a Mexican investigation into whether the Cincinnati-based company might owe millions of dollars in back taxes. The Procter & Gamble Company (NYSE:PG) shares moved down -1.07% in last trading session and ended the day at $84.33. PG Gross Margin is 48.90% and its return on assets is 8.00%. The Procter & Gamble Company (NYSE:PG) quarterly performance is 7.26%.

On Sep 8, Nordic American Offshore Ltd. (NYSE:NAO) has entered into two new contracts with a major oil-company in the UK for one year with a one year option, the company said in its press release. On 25 September, Nordic American Offshore Ltd. (NYSE:NAO) shares moved down -0.61% and was closed at $17.90. NAO EPS growth in last 5 year was 0.00%. Nordic American Offshore Ltd. (NYSE:NAO) year to date (YTD) performance is 20.95%.

Infinera Corp. (NASDAQ:INFN) President David F. Welch unloaded 22,500 shares of the company’s stock on the open market in a transaction dated Monday, September 22nd. The shares were sold at an average price of $11.20, for a total transaction of $252,000.00. Following the sale, the president now directly owns 14,132 shares of the company’s stock, valued at approximately $158,278. Infinera Corporation (NASDAQ:INFN) ended the last trading day at $10.74. Company weekly volatility is calculated as 3.50% and price to cash ratio as 4.23. Infinera Corporation (NASDAQ:INFN) showed a weekly performance of -7.09%.

Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) has launched its generic version of Sunovion Pharmaceuticals Inc.’s Xopenex inhalation solution (0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL unit-dose vials) in the U.S. It can be used only with a nebulizer. Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) shares advanced 0.17% in last trading session and ended the day at $53.35. RDY Gross Margin is 57.40% and its return on assets is 20.60%. Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) quarterly performance is 27.78%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone